Bavarian Nordic to hold Capital Markets Days in February 2024
2023年11月23日 - 2:00AM
Bavarian Nordic to hold Capital Markets Days in February 2024
COPENHAGEN, Denmark, November 22, 2023 –
Bavarian Nordic A/S (OMX: BAVA) will hold a series of capital
markets days in February 2024 for investors and analysts across
Europe and the U.S.
At these half-day events, the chairman and
senior management of Bavarian Nordic will provide an update on the
company's strategy as well as a deep dive into its two business
areas: travel health and public preparedness, and the opportunities
ahead.
The capital market days are scheduled the
following days:
Monday, February 26, 2024, in CopenhagenTuesday,
February 27, 2024, in LondonWednesday, February 28, 2024, in New
York City
Participation is by invitation only. Additional
information on the agenda, venue and presenters for the event will
be shared with invitees later and will also become available on the
company’s website: www.bavarian-nordic.com/cmd.
About Bavarian NordicBavarian Nordic is a
fully integrated vaccines company focused on the research and
development, manufacturing and commercialization of life-saving
vaccines. We are a global leader in smallpox and mpox vaccines,
which have been developed through our long-standing partnership
with the U.S. Government to enhance the public health preparedness
and have a strong portfolio of vaccines for travelers and endemic
diseases. For more information visit www.bavarian-nordic.com.
ContactsRolf Sass Sørensen (Europe) Vice
President Investor Relations Tel: +45 61 77 47
43investor@bavarian-nordic.com
Graham Morrell (US) Paddock Circle Advisors Tel: +1
781 686 9600graham@paddockcircle.com
Bavarian Nordic AS (TG:BV3)
過去 株価チャート
から 8 2024 まで 9 2024
Bavarian Nordic AS (TG:BV3)
過去 株価チャート
から 9 2023 まで 9 2024